Target intelligence / Profile preview

V-type proton ATPase subunit C1 (ATP6V1C1)

Target
ATP6V1C1
Molecular classification
Enzyme, Transporter, Proton pump
01

Overview

V-type proton ATPase subunit C1 (ATP6V1C1) is a key component of the vacuolar-type H^(+)-ATPase (V-ATPase) complex, an ATP-dependent proton pump responsible for acidifying a variety of intracellular compartments in eukaryotic cells, including endosomes, lysosomes, and secretory vesicles[2][3][4]. It is encoded by the ATP6V1C1 gene on chromosome 8 and belongs to the V1 domain of V-ATPase, which contains the catalytic ATP-hydrolyzing site and subunits essential for energy transduction. The C1 subunit is directly involved in regulating V-ATPase assembly, controlling the reversible dissociation of the peripheral V1 and membrane-integral V0 sectors—a key mechanism in modulating pump function in response to cellular signals[2]. ATP6V1C1 is ubiquitously expressed but especially critical in osteoclasts, where it supports extracellular acidification necessary for bone resorption[1]. Inhibition or deficiency of ATP6V1C1 impairs proton transport and acidification processes, resulting in disrupted vesicular trafficking, protein degradation, and cellular signaling, and is implicated in pathologies such as impaired bone remodeling, cancer, and neurodegenerative diseases[1][2][3][4]. Drugs such as bafilomycin A1 and concanamycin inhibit V-ATPase by targeting this or closely related subunits, affecting vescicular pH homeostasis and cellular metabolism.

Other names
ATP6CATP6DVATCVma5Vacuolar proton pump subunit C1H(+)-transporting ATPase chain CV-ATPase C subunitV-ATPase subunit C1Vacuolar ATP synthase subunit CEC 3.6.3.14FLJ20057
02

Mechanism of action

Inhibition of proton translocation across organelle/plasma membrane (disrupts acidification) Blockade of lysosomal acidification (impairs autophagy, protein degradation)

03

Biological functions

Acidification of intracellular compartmentsProton transportProtein sortingReceptor-mediated endocytosisZymogen activationVesicle traffickingBone resorption (osteoclast function)
04

Disease associations

CancerOsteopetrosis and bone diseasesNeurodegenerative diseaseInfection
05

Safety considerations

Targeting can impair general cellular acidification, affecting multiple organ systemsPotential toxicity due to broad role in endosomal/lysosomal functionEffects on bone turnover when inhibited systemically
06

Interacting drugs

Bafilomycin A1 (V-ATPase inhibitor)

1 more in the full profile.

07

Biomarkers

Elevated expression in osteoclasts for bone resorptionV-ATPase activity as marker in certain cancers and metabolic disorders

Beyond the preview

Go deeper on V-type proton ATPase subunit C1 (ATP6V1C1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on V-type proton ATPase subunit C1 (ATP6V1C1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call